Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
27
28
29
30
31
1
2
12:00 AM - NextGen UGM 2025
3
4
6
7
8
9
10
11
12
13
14
15
16
17
10:00 AM - MEDICA 2025
18
19
20
21
22
23
24
25
26
27
28
29
30
NextGen UGM 2025
2025-11-02 - 2025-11-05    
12:00 am
NextGen UGM 2025 is set to take place in Nashville, TN, from November 2 to 5 at the Gaylord Opryland Resort & Convention Center. This [...]
Preparing Healthcare Systems for Cyber Threats
2025-11-05    
2:00 pm
Healthcare is facing an unprecedented level of cyber risk. With cyberattacks on the rise, health systems must prepare for the reality of potential breaches. In [...]
MEDICA 2025
2025-11-17 - 2025-11-20    
10:00 am - 5:00 pm
Expert Exchange in Medicine at MEDICA – Shaping the Future of Healthcare MEDICA unites the key players driving innovation in medicine. Whether you're involved in [...]
Events on 2025-11-02
NextGen UGM 2025
2 Nov 25
TN
Events on 2025-11-05
Events on 2025-11-17
MEDICA 2025
17 Nov 25
40474 Düsseldorf
Latest News

Trial tests EHR alerts in seniors

Northwestern Medicine researchers achieved notable reductions in unnecessary testing using EHR alerts. The study demonstrated substantial decreases in unnecessary prostate-specific antigen testing, urine testing, and prescription of hypoglycemic agents. EHR alerts resulted in an 8.7% decrease in PSA testing, a 5.5% reduction in urine testing, and a 1.4% decline in overtreating blood sugar. The study’s focus on potential harms, social norms, and social accountability contributed to designing effective alerts. This contrasts with limited success in changing clinician behavior through other research. Lead author Stephen Persell underscores the importance of incorporating these elements for effective alerts.

Examining older men for prostate cancer may not significantly prolong their lives, but it may expose them to potential harms from unnecessary treatments like surgery or radiation. These treatments could lead to issues such as urinary problems, sexual dysfunction, or rectal bleeding. A parallel risk exists when testing women for urinary tract infections and treating older adults with diabetes using blood glucose-lowering drugs, potentially resulting in dangerous outcomes.